{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:50:06Z","timestamp":1788922206983,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 DA051658"],"award-info":[{"award-number":["U01 DA051658"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG3DA057850"],"award-info":[{"award-number":["UG3DA057850"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbrc.2025.151995","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T02:27:26Z","timestamp":1746844046000},"page":"151995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice"],"prefix":"10.1016","volume":"770","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5562-1312","authenticated-orcid":false,"given":"Brooke K.","family":"Hoppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Seaman Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5920-3440","authenticated-orcid":false,"given":"Bryan","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6934-4050","authenticated-orcid":false,"given":"Dustin","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3395-6776","authenticated-orcid":false,"given":"Carly","family":"Baehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2602-3273","authenticated-orcid":false,"given":"Haydon J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2853-7822","authenticated-orcid":false,"given":"Sujata G.","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Baldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Berner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2197-8177","authenticated-orcid":false,"given":"David P.","family":"AuCoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Runyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pravetoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151995_bib1","year":"2024"},{"key":"10.1016\/j.bbrc.2025.151995_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110985","article-title":"Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services","volume":"252","author":"Wagner","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbrc.2025.151995_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40122-023-00481-6","article-title":"New synthetic opioids: clinical considerations and dangers","volume":"12","author":"Edinoff","year":"2023","journal-title":"Pain. Ther."},{"key":"10.1016\/j.bbrc.2025.151995_bib4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.15585\/mmwr.mm7226a4","article-title":"Illicitly manufactured fentanyl-involved overdose deaths with detected xylazine - united States, January 2019-June 2022","volume":"72","author":"Kariisa","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.bbrc.2025.151995_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jat\/bks078","article-title":"Analysis of clothing and urine from Moscow theatre siege casualties reveals carfentanil and remifentanil use","volume":"36","author":"Riches","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.bbrc.2025.151995_bib6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1067\/mem.2003.148","article-title":"Unexpected \u201cgas\u201d casualties in Moscow: a medical toxicology perspective","volume":"41","author":"Wax","year":"2003","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.bbrc.2025.151995_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/toxics11010052","article-title":"Drugs as chemical weapons: past and perspectives","volume":"11","author":"Pitschmann","year":"2023","journal-title":"Toxics"},{"key":"10.1016\/j.bbrc.2025.151995_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.110715","article-title":"Carfentanil - from an animal anesthetic to a deadly illicit drug","volume":"320","author":"Zawilska","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.bbrc.2025.151995_bib9","unstructured":"Carfentanil signals alert | millennium health, millennium health LLC (n.d.). https:\/\/www.millenniumhealth.com\/signalsalert\/carfentanil2024\/(accessed November 13, 2024)."},{"key":"10.1016\/j.bbrc.2025.151995_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11419-017-0379-4","article-title":"Fentanyls continue to replace heroin in the drug arena: the cases of ocfentanil and carfentanil","volume":"36","author":"Misailidi","year":"2018","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.bbrc.2025.151995_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm6905a2","article-title":"Carfentanil outbreak \u2014 florida, 2016\u20132017","volume":"69","author":"Delcher","year":"2020","journal-title":"MMWR (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.bbrc.2025.151995_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(92)90685-W","article-title":"Pharmacological profiles of fentanyl analogs at \u03bc, \u03b4 and \u03ba opiate receptors","volume":"213","author":"Maguire","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151995_bib13","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1002\/phar.2117","article-title":"The pharmacokinetics and pharmacodynamics of carfentanil after recreational exposure: a case report","volume":"38","author":"Uddayasankar","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbrc.2025.151995_bib14","doi-asserted-by":"crossref","unstructured":"N. Alhosan, D. Cavallo, M. Santiago, E. Kelly, G. Henderson, Slow dissociation kinetics of fentanyls and nitazenes correlates with reduced sensitivity to naloxone reversal at the \u03bc-opioid receptor, British Journal of Pharmacology n\/a (n.d.). https:\/\/doi.org\/10.1111\/bph.17376.","DOI":"10.1111\/bph.17376"},{"key":"10.1016\/j.bbrc.2025.151995_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s12630-019-01294-y","article-title":"Carfentanil: a narrative review of its pharmacology and public health concerns","volume":"66","author":"Leen","year":"2019","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.bbrc.2025.151995_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.04.002","article-title":"Evidence for nonlinear accumulation of the ultrapotent fentanyl analog, carfentanil, after systemic administration to male rats","volume":"158","author":"Bergh","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrc.2025.151995_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/08971900221097173","article-title":"Stigma by Association: to what extent is the attitude toward naloxone affected by the stigma of opioid use disorder?","volume":"36","author":"Adeosun","year":"2023","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.bbrc.2025.151995_bib18","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1038\/s41598-022-09601-2","article-title":"Naloxone's dose-dependent displacement of [11C]carfentanil and duration of receptor occupancy in the rat brain","volume":"12","author":"Kang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.151995_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/acem.13034","article-title":"Fatal fentanyl: one pill can kill","volume":"24","author":"Sutter","year":"2017","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.bbrc.2025.151995_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/08897077.2018.1449053","article-title":"Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply","volume":"40","author":"Bell","year":"2019","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.bbrc.2025.151995_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther. Adv. Drug. Saf."},{"key":"10.1016\/j.bbrc.2025.151995_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0009-9236(96)90173-3","article-title":"Buprenorphine and naloxone interactions in opiate-dependent volunteers","volume":"60","author":"Mendelson","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151995_bib23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ALN.0000000000004622","article-title":"Opioid overdose: limitations in naloxone reversal of respiratory depression and prevention of cardiac arrest","volume":"139","author":"van Lemmen","year":"2023","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbrc.2025.151995_bib24","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1038\/s41467-023-43126-0","article-title":"Investigation of monoclonal antibody CSX-1004 for fentanyl overdose","volume":"14","author":"Bremer","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151995_bib25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/cpt.2696","article-title":"Development of a translational model to assess the impact of opioid overdose and naloxone dosing on respiratory depression and cardiac arrest","volume":"112","author":"Mann","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151995_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13543784.2023.2187286","article-title":"The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis","volume":"32","author":"Martinez","year":"2023","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.bbrc.2025.151995_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2122507","article-title":"Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development","volume":"18","author":"Hicks","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.bbrc.2025.151995_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2024.03.008","article-title":"The fentanyl-specific antibody FenAb024 can shield against carfentanil effects","volume":"396","author":"Urban","year":"2024","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbrc.2025.151995_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.120.000124","article-title":"Monoclonal antibodies counteract opioid-induced behavioral and toxic effects in mice and rats","volume":"375","author":"Baehr","year":"2020","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.bbrc.2025.151995_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000542-197605000-00008","article-title":"Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action","volume":"44","author":"Ngai","year":"1976","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbrc.2025.151995_bib31","first-page":"634","article-title":"The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin","volume":"112","author":"Mankarious","year":"1988","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bbrc.2025.151995_bib32","first-page":"1098","article-title":"Extending human IgG half-life using structure-guided design","volume":"10","author":"Booth","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.bbrc.2025.151995_bib33","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-025-06751-9","article-title":"A humanized monoclonal antibody attenuates fentanyl self-administration and reverses and prevents fentanyl-induced ventilatory depression in rhesus monkeys","author":"Galbo-Thomma","year":"2025","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbrc.2025.151995_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4049\/jimmunol.2400170","article-title":"Monoclonal antibodies engineered with Fc region mutations to extend protection against fentanyl toxicity","volume":"213","author":"Khaimraj","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2025.151995_bib35","doi-asserted-by":"crossref","first-page":"9604","DOI":"10.3390\/ijms23179604","article-title":"Monoclonal antibody engineering and design to modulate FcRn activities: a comprehensive review","volume":"23","author":"Ramdani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151995_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.112676","article-title":"A novel differential scanning fluorimetry analysis of a humanized anti-cocaine mAb and its ligand binding characteristics","volume":"476","author":"Kirley","year":"2020","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbrc.2025.151995_bib37","doi-asserted-by":"crossref","first-page":"42506","DOI":"10.1021\/acsomega.4c06617","article-title":"Structure-based engineering of monoclonal antibodies for improved binding to counteract the effects of fentanyl and carfentanil","volume":"9","author":"Rodarte","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbrc.2025.151995_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184876","article-title":"Safety and efficacy of an oxycodone vaccine: addressing some of the unique considerations posed by opioid abuse","volume":"12","author":"Raleigh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.151995_bib39","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1021\/acs.jmedchem.0c01042","article-title":"Therapeutic and prophylactic vaccines to counteract fentanyl use disorders and toxicity","volume":"63","author":"Robinson","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151995_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/mps7030049","article-title":"Simple determination of affinity constants of antibodies by competitive immunoassays","volume":"7","author":"Fischer","year":"2024","journal-title":"Methods Protoc."},{"key":"10.1016\/j.bbrc.2025.151995_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.str.2022.11.008","article-title":"Structures of drug-specific monoclonal antibodies bound to opioids and nicotine reveal a common mode of binding","volume":"31","author":"Rodarte","year":"2023","journal-title":"Structure"},{"key":"10.1016\/j.bbrc.2025.151995_bib42","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1021\/jacs.9b04872","article-title":"Monoclonal antibodies for combating synthetic opioid intoxication","volume":"141","author":"Smith","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbrc.2025.151995_bib43","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1021\/acsptsci.3c00031","article-title":"Catalytic antibody blunts carfentanil-induced respiratory depression","volume":"6","author":"Lin","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bbrc.2025.151995_bib44","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acschemneuro.3c00455","article-title":"An engineered human-antibody fragment with fentanyl pan-specificity that reverses carfentanil-induced respiratory depression","volume":"14","author":"Eubanks","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbrc.2025.151995_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108838","article-title":"Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: a systematic review","volume":"226","author":"Winstanley","year":"2021","journal-title":"Drug Alcohol Depend."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:11:32Z","timestamp":1781701892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25007090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":45,"alternative-id":["S0006291X25007090"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151995","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151995"}}